198 related articles for article (PubMed ID: 2642629)
1. Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure.
Packer M
Am J Cardiol; 1989 Jan; 63(2):41A-45A. PubMed ID: 2642629
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.
Packer M; Carver JR; Rodeheffer RJ; Ivanhoe RJ; DiBianco R; Zeldis SM; Hendrix GH; Bommer WJ; Elkayam U; Kukin ML
N Engl J Med; 1991 Nov; 325(21):1468-75. PubMed ID: 1944425
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of phosphodiesterase inhibition with milrinone in combination with converting enzyme inhibitors in patients with heart failure. The Milrinone Multicenter Trials Investigators.
Colucci WS; Sonnenblick EH; Adams KF; Berk M; Brozena SC; Cowley AJ; Grabicki JM; Kubo SA; LeJemtel T; Littler WA
J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):113A-118A. PubMed ID: 8376682
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic achievements of phosphodiesterase inhibitors and the future.
Jewitt DE
Eur Heart J; 1989 Aug; 10 Suppl C():53-9. PubMed ID: 2680498
[TBL] [Abstract][Full Text] [Related]
5. Controlled and uncontrolled studies of phosphodiesterase III inhibitors in contemporary cardiovascular medicine.
Hood WB
Am J Cardiol; 1989 Jan; 63(2):46A-53A. PubMed ID: 2521268
[TBL] [Abstract][Full Text] [Related]
6. Long-term oral therapy of congestive heart failure with phosphodiesterase inhibitors.
Wood MA; Hess ML
Am J Med Sci; 1989 Feb; 297(2):105-13. PubMed ID: 2521982
[TBL] [Abstract][Full Text] [Related]
7. [Response to milrinone treatment in patients with chronic congestive heart failure].
Zeng H; Wen S; Huang D; Liu X; Fang Y
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):246-7, 259. PubMed ID: 12515150
[TBL] [Abstract][Full Text] [Related]
8. Clinical results with oral milrinone in heart failure.
DiBianco R
Eur Heart J; 1989 Aug; 10 Suppl C():44-52. PubMed ID: 2680497
[TBL] [Abstract][Full Text] [Related]
9. Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study.
Eichhorn EJ; Tandon PK; DiBianco R; Timmis GC; Fenster PE; Shannon J; Packer M
J Am Coll Cardiol; 1993 Mar; 21(3):634-40. PubMed ID: 8436744
[TBL] [Abstract][Full Text] [Related]
10. Survival of patients with severe congestive heart failure treated with oral milrinone.
Baim DS; Colucci WS; Monrad ES; Smith HS; Wright RF; Lanoue A; Gauthier DF; Ransil BJ; Grossman W; Braunwald E
J Am Coll Cardiol; 1986 Mar; 7(3):661-70. PubMed ID: 3950244
[TBL] [Abstract][Full Text] [Related]
11. Milrinone. A preliminary review of its pharmacological properties and therapeutic use.
Young RA; Ward A
Drugs; 1988 Aug; 36(2):158-92. PubMed ID: 3053125
[TBL] [Abstract][Full Text] [Related]
12. Milrinone in congestive heart failure: observations on ambulatory ventricular arrhythmias.
Holmes JR; Kubo SH; Cody RJ; Kligfield P
Am Heart J; 1985 Oct; 110(4):800-6. PubMed ID: 4050652
[TBL] [Abstract][Full Text] [Related]
13. The new inotropic phosphodiesterase inhibitors.
el Allaf D; D'Orio V; Carlier J
Arch Int Physiol Biochim; 1984 Nov; 92(4):S69-79. PubMed ID: 6085243
[TBL] [Abstract][Full Text] [Related]
14. [New positive inotropic drugs in acute and chronic heart failure].
Follath F
Schweiz Rundsch Med Prax; 1992 May; 81(21):704-7. PubMed ID: 1351309
[TBL] [Abstract][Full Text] [Related]
15. Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? III. Antagonist's viewpoint.
Colucci WS
J Am Coll Cardiol; 1988 Aug; 12(2):566-9. PubMed ID: 2899101
[No Abstract] [Full Text] [Related]
16. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
Colucci WS; Wright RF; Braunwald E
N Engl J Med; 1986 Feb; 314(6):349-58. PubMed ID: 2418353
[No Abstract] [Full Text] [Related]
17. Milrinone: basic and clinical pharmacology and acute and chronic management.
Shipley JB; Tolman D; Hastillo A; Hess ML
Am J Med Sci; 1996 Jun; 311(6):286-91. PubMed ID: 8659556
[TBL] [Abstract][Full Text] [Related]
18. Milrinone, a new agent for the treatment of congestive heart failure.
Hasegawa GR
Clin Pharm; 1986 Mar; 5(3):201-5. PubMed ID: 3514085
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.
Baim DS; McDowell AV; Cherniles J; Monrad ES; Parker JA; Edelson J; Braunwald E; Grossman W
N Engl J Med; 1983 Sep; 309(13):748-56. PubMed ID: 6888453
[TBL] [Abstract][Full Text] [Related]
20. Placebo-controlled trial of oral enoximone in end-stage congestive heart failure refractory to optimal treatment.
Dubourg O; Delorme G; Hardy A; Beauchet A; Tarral A; Bourdarias JP
Int J Cardiol; 1990 Jul; 28 Suppl 1():S33-42; discussion S43. PubMed ID: 2145237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
